news

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

Meijing AI News,Soochow Securities released a research report on August 27, giving Tongce Medical (600763.SH, latest price: 41.19 yuan) a buy rating. The reasons for the rating mainly include: 1) Implants have achieved accelerated growth, and the growth trend of the main hospital has improved; 2) The company's gross profit margin and net profit margin have slightly decreased, and the expense rate has basically remained stable. Risk warning: The risk of the number of dental implants growing less than expected, the risk of hospital expansion or integration not meeting expectations, the risk of core doctors losing, and the risk of intensified industry competition.

AI comment: Tongce Medical has received attention from 5 brokerage research reports in the past month, with 3 purchases and 2 increases in holdings. The average target price is 43.05 yuan, which is 1.86 yuan higher than the latest price of 41.19 yuan. The average target price has increased by 4.52%.

Every headline (nbdtoutiao)——

(Reporter Chen Pengcheng)

Disclaimer: The content and data in this article are for reference only and do not constitute investment advice. Please verify before use. You will be responsible for your own risks if you act accordingly.

Daily Economic News